Product Information
RUFINAMIDE 200 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.8636 per EA under NDC 42571039112. Its NADAC has been published 124 times since Feb 14, 2024.
Strength
200 mg/1
Manufacturer
Micro Labs LimitedNDC
42571039112
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RUFINAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216688On Market Since
7/1/2023
Price Statistics
The NADAC for RUFINAMIDE 200 MG TABLET has been published 124 times since Feb 14, 2024, and over the history we have for it it has declined 56.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8636 per EA |
|---|---|
| All-time high | $1.9811 (Apr 10, 2024) |
| All-time low | $0.8636 (Jun 17, 2026) |
| 52-week high | $1.5412 |
| 52-week low | $0.8636 |
| Median price | $1.4713 |
| Average price | $1.4202 |
| Largest weekly change | -14.2% (Nov 19, 2025) |
| Weeks tracked | 124 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the RUFINAMIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RUFINAMIDE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 200 MG TABLET, manufactured by Micro Labs Limited, is $0.8636 per EA (NDC 42571039112), effective Jun 24, 2026.
How has the price of RUFINAMIDE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for RUFINAMIDE 200 MG TABLET has declined 56.4%. It has been tracked across 124 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for RUFINAMIDE 200 MG TABLET?
Since Feb 14, 2024, the NADAC for RUFINAMIDE 200 MG TABLET has ranged from a low of $0.8636 (Jun 17, 2026) to a high of $1.9811 (Apr 10, 2024), with a median of $1.4713 per EA.
Are there cheaper alternatives to RUFINAMIDE 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RUFINAMIDE 200 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures RUFINAMIDE 200 MG TABLET?
RUFINAMIDE 200 MG TABLET (NDC 42571039112) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification